BIOLOGIC THERAPY OF PSORIATIC ARTHRITIS

Abstract Views: 601
PDF: 539
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Psoriatic arthritis is now recognized as a potentially serious and disabling disease. Traditional therapies have not been very effective in controlling signs and symptoms or preventing progression of damage. Based on the pathogenesis of the disease new therapies have been introduced, particularly anti-TNF agents and anti-T cell agents. Several of those have shown excellent responses in clinical variables, health related quality of life and function, and in preventing radiological progression. However, not all patients have responded, and the long-term safety of these drugs remains unknown. Key words: Psoriatic arthritis, treatment, biologic agents

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Gladman, D. (2007). BIOLOGIC THERAPY OF PSORIATIC ARTHRITIS. Reumatismo, 59(s1), 85–87. https://doi.org/10.4081/reumatismo.2007.1s.85